Domenico Coppola, Marianna szabo, David Boulware, et al. Correlation of Osteopontin protein expression and pathological stage across a wide variety of tumor histologies[J]. Clinical Cancer Research,2004,10:184-190.
Yohko UK, Jonathan Sleeman, Hideki Fujii, et al. CD44 Variants but not CD44s Cooperate with ?1-containing Integrins to Permit Cells to Bind to Osteopontin Independently of Arginine-glycine-aspartic Acid, thereby Stimulating Cell Motility and Chemotaxis[J]. Cancer Research, 1999,59: 219-226.
Hofmann M, Rudy W, Gunthert U, et al. A link between ras and metastatic behavior of tumor cells; ras induces CD44 promoter activity and leads to low level expressions of metastasis-specific variants of CD44 in CREF cells[J].Cancer Res,1993,53:1516-1521.
Das R, Mahabeleshwar GH, Kundu GC. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells[J]. J Biol Cheml,2004,279:11051-11064.